These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29807471)

  • 21. Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal Study.
    Piñero-López MÁ; Modamio P; Lastra CF; Mariño EL
    J Med Internet Res; 2016 May; 18(5):e100. PubMed ID: 27226241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of interventions to improve medication information for low health literate populations.
    Wali H; Hudani Z; Wali S; Mercer K; Grindrod K
    Res Social Adm Pharm; 2016; 12(6):830-864. PubMed ID: 26926671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness.
    Miller MJ; Schmitt MR; Allison JJ; Cobaugh DJ; Ray MN; Saag KG
    Ann Pharmacother; 2010 Feb; 44(2):274-84. PubMed ID: 20103612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient characteristics influencing evaluation of written medicine information: lessons for patient education.
    Koo MM; Krass I; Aslani P
    Ann Pharmacother; 2005 Sep; 39(9):1434-40. PubMed ID: 16046486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory agencies' recommendations for medicine information leaflets: Are they in line with research findings?
    Young A; Tordoff J; Smith A
    Res Social Adm Pharm; 2018 Feb; 14(2):196-202. PubMed ID: 28285793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Over the counter drugs--a new era in Israel].
    Abadi-Korek I; Vaknin S; Marom E; Shemer J; Luxenburg O
    Harefuah; 2011 Jan; 150(1):29-32, 69, 68. PubMed ID: 21449153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of counseling practices on prescription medicines in community pharmacies.
    Puspitasari HP; Aslani P; Krass I
    Res Social Adm Pharm; 2009 Sep; 5(3):197-210. PubMed ID: 19733821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumer satisfaction with National Alliance on Mental Illness written medicine information.
    Colvard MD; Jackson MT; Oliveira R; Scholtes K; Burghart S; Gutíerrez CA; Moore TA; Saldaña SN; VandenBerg A
    Ment Health Clin; 2017 Mar; 7(2):74-80. PubMed ID: 29955502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Providing patients with written medication information.
    Buck ML
    Ann Pharmacother; 1998 Sep; 32(9):962-9. PubMed ID: 9762384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Government regulation of pricing and reimbursement of prescription medicines: results of a recent multi-country review.
    Kingham R; Wheeler J
    Food Drug Law J; 2009; 64(1):101-14. PubMed ID: 19998574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thai Patients' Drug Safety Knowledge and Perceptions Relating to Different Forms of Written Medicine Information: A Comparative Study.
    Wongtaweepkij K; Krska J; Pongpunna S; Pongwecharak J; Jarernsiripornkul N
    Patient Prefer Adherence; 2022; 16():1141-1152. PubMed ID: 35517042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More medicines for children: impact of the EU paediatric regulation.
    Nordenmalm S; Tomasi P; Pallidis C
    Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicines reclassification from a pharmaceutical industry perspective: An international qualitative study.
    Gauld NJ; Kelly FS; Emmerton LM; Kurosawa N; Bryant LJM; Buetow SA
    Res Social Adm Pharm; 2019 Apr; 15(4):387-394. PubMed ID: 30917892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.